Here are four announcements from the American Cancer Society reported by Becker's since Feb. 11:
Uncategorized
The American Cancer Society awarded over $16 million in grants to establish cancer health equity research centers at minority-serving institutions of higher learning across the country, the organization said Feb. 24.
Six cardiologists who recently joined new practices or stepped into new roles:
Multisystem inflammatory syndrome, or MIS-C, is rare in people ages 12 to 20 who are vaccinated against COVID-19, a study published Feb. 22 in The Lancet suggests.
Researchers at Los Angeles-based Cedars-Sinai's Smidt Heart Institute have created an artificial intelligence tool that can identify and distinguish between two overlooked heart conditions: hypertrophic cardiomyopathy and cardiac amyloidosis, the institute said Feb. 23.
Newport Beach, Calif.-based Hoag Memorial Hospital Presbyterian has selected Thomas Wang, MD, PhD, to serve as medical director of its melanoma/advanced skin cancer program.
People ages 40 to 75 who are at high risk for cardiovascular heart disease should take a statin to prevent a first heart attack or stroke, a panel of U.S. health experts recommended Feb. 22.
Los Angeles-based City of Hope was awarded a $4.9 million grant for its department of stem cell biology and regenerative medicine, the cancer research group said Feb. 22.
Morristown, N.J.-based Atlantic Health System named Mohamad Cherry, MD, medical director of its hematology and cellular therapy programs, it said Feb. 23.
Yale Cancer Center is partnering with the National Brain Tumor Society to launch a flagship research initiative focused on DNA damage, the cancer center said Feb. 22.